Change over period: —
NSE · LASA
LASA
-66.7% from the 52-week high · +0.0% above the low
Lasa Supergenerics Ltd. engages in the manufacture of veterinary preparations. The company is headquartered in Mumbai, Maharashtra. The company went IPO on 2017-09-21. The firm is engaged in the business of manufacturing, trading, producing, processing, preparing, treating chemicals, API, pharmaceuticals, drugs and others. The company specializes in catalyst chemistry and manufactures anthelmintic/veterinary API products. The firm's products include API products, other API products, animal feed ingredients and reagents for therapeutic use. Its API products include Albendazole, Fenbendazole, Oxfendazole, Providone Iodine, Nitroxylene, Ricobendazole, Halquinol and others. Its animal feed ingredients include potassium iodide, cobalt sulfate, sodium selenate, ethylediamine dihydroiodide and vanadyl sulfate. Its reagents for therapeutic use include cetylpyridinium chloride, bismuth subsalicylate and sodium selenite. The firm's manufacturing facility is located at Mahad and Chiplun, Maharashtra.
The short version. Promoter holding was 53.65% in Sep 2026, up 0.00 points over 8 quarters.
1 · The price
How has the stock traded?
LASA trades 66.7% below its 52-week high and 0.0% above its 52-week low.
4 · The owners
Who holds it, and are they adding?
Unchanged over 8 quarters.
+0 versus the previous month.
Shareholding pattern (%)
Quarter by quarter
| Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Sep 2026 | Change | |
|---|---|---|---|---|---|---|---|---|---|
| Promoter | 53.65 | 53.65 | 53.65 | 53.65 | 53.65 | 53.65 | 53.65 | 53.65 | 0.0 |
| FII | 0.01 | 0 | 0 | 0.47 | 0 | 0 | 0 | 0 | -0.01 |
| DII | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Public | 46.34 | 46.35 | 46.35 | 45.88 | 46.35 | 46.35 | 46.35 | 46.35 | +0.01 |
Mutual fund holdings · Oct 2026
0 schemes hold this stock
0 the month before.
5 · The model view
What does our factor model say?
Factor scores, model flags and screen results for LASA are part of the Wright portfolio review.
Run your free portfolio reviewWatchouts
What to review
Model flags are shown inside the portfolio review, alongside your other holdings.
Related stocks
Other Pharmaceuticals & Biotechnology stocks
Quick answers
Common questions about LASA
What is the market cap of LASA?
LASA has a market capitalisation of about ₹22 crore.
How are LASA's latest results?
Promoter holding was 53.65% in Sep 2026, up 0.00 points over 8 quarters.
Who owns LASA?
As of Sep 2026, shareholding was: Promoter 53.65%, Public 46.35%.
How many mutual funds hold LASA?
0 mutual fund schemes held LASA in October 2026. That compares with 0 the month before.
Corporate actions
Recent dividends, bonuses and splits
- 16 Sep 2022 · Dividend - Rs. 0.25
- 15 Sep 2021 · Dividend - Rs. 0.25
Research data on this page is provided under Wright Research's SEBI Research Analyst registration. The Terms & Conditions of our Research Analyst services apply.